Fikriye ZENGİN KARADAYI, Mehmet Murat KIŞLA, Zeynep ATEŞ ALAGÖZ, Rahman BAŞARAN, Binay CAN EKE

Synthesis, antioxidant activity, molecular docking and ADME studies of novel pyrrolebenzimidazole derivatives

Several 5-(alkylsulfonyl)-1-substituted-2-(1H-pyrrol-2-yl)-1H-benzo[d]imidazole derivatives were synthesized and their antioxidant activities were investigated using lipid peroxidation (LPO) and 7-ethoxyresorufin O-deethylase (EROD) assays. Docking analysis with Human NAD[P]H-Quinone oxidoreductase 1 (NQO1) was also performed to gather thorough information about these compounds that have antioxidant activities. Moreover, their molecular descriptors and ADME properties were calculated using the SwissADME online program. As a result, most of our compounds possessed better affinity and created ample interactions with NQO1. The most potent compound 5j had LP inhibition value of 3.73 nmol/mg/min. Other compounds exhibited moderate activity on LP levels comparing to standard butylated hydroxy toluene (BHT). However, the inhibitory effect on EROD activity was not significant.

PDF

___

1. Ates-Alagoz Z, Can-Eke B, Coban T, Iscan M, Buyukbıngol E. Antioxidant properties of novel benzimidazole retinoids. Archiv der Pharmazie 2004; 337: 188-192.
2. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organization Journal 2012; 5 (1): 9-19.
3. Ramana KV, Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity 2014; 360438.
4. Yin H, Libin X, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews 2011; 111 (10): 5944–5972.
5. Pey AL, Megarity CF, Timson DJ. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Bioscience Reports 2019; 39 (1): BSR20180459.
6. Faig M, Bianchet MA, Talalay P, Chen S, Winski S et al. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. Proceedings of the National Academy of Sciences of the United States of America 2000; 97 (7): 3177-3182
7. Narule MN, Gaidhane MK, Gaidhane PK. Synthesis, characterization, biologically and antioxidant active of some 2-substitued 3,5-dimethyl4-ethoxy carbonyl pyrrole derivatives. Journal of Pharmacy Research 2014; 6: 626-632.
8. Shanty AA, Philip JE, Sneha EJ, Prathapachandra Kurup MR, Balachandran S et al. Synthesis, characterization and biological studies of Schiff bases derived from heterocyclic moiety. Bioorganic Chemistry 2017; 70: 67-73.
9. Kerimov I, Kilcigil G, Özdamar ED, Eke B, Çoban T et al. Design, one pot and microwave assisted synthesis of 2-amino/5-aryl-1,3,4- oxadiazoles bearing benzimidazole moiety as antioxidant. Archiv der Pharmazie 2012; 345 (7): 549-556.
10. Kilcigil G, Alp AS, Coban T, Ozdamar ED, Eke B. Synthesis and evaluation of antioxidant properties of novel 2-[2-(4-chlorophenyl) benzimidazole-1-yl]-N-(2-arylmethylene amino) acetamides and 2-[2-(4-chlorophenyl)benzimidazole-1-yl]-N-(4-oxo-2-arylthiazolidine-3-yl) acetamides-I. Chemical Biology & Drug Design 2012; 76: 869-877.
11. Ayhan-Kilcigil G, Kus C, Coban T, Ozdamar ED, Can-Eke B. Identification of a novel series of N-Phenyl-5-[(2-phenylbenzimidazol-1-yl) methyl]-1,3,4-oxadiazol-2-amines as potent antioxidants and radical scavengers. Archiv der Pharmazie 2014; 347 (4): 276-282.
12. Alp AS, Kilcigil G, Ozdamar ED, Eke B. Synthesis and evaluation of antioxidant activities of novel 1,3,4-oxadiazole and imine containing 1H-benzimidazoles. Turkish Journal of Chemistry 2015; 39: 42-53.
13. Iscan MY, Buyukbingol E, Iscan M, Sahin F, Safak C. Effects of 2-arylbenzimidazoles on rat hepatic microsomal monooxygenase system. Comparative Biochemistry and Physiology 1989; 92C: 109-115.
14. Little PJ, Ryan AJ. Inhibitors of hepatic mixed function oxidazes. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats. Journal of Medicinal Chemistry 1982; 25: 622-626.
15. Dickens M, Bridges JW. The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P-450 and the inhibition of monooxygenation. Biochemical Pharmacology 1982; 31: 1315-1320.
16. Murray M, Ryan AJ. The binding to oxidized cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds. Chemico-Biological Interactions 1983; 43: 341-351.
17. Ates-Alagoz Z. Antioxidant activities of retinoidal benzimidazole or indole derivatives in in vitro model systems, Current Medicinal Chemistry, Special Issue “Chemistry and Biology of Antioxidants” 2013; 20 (36): 4633-4639.
18. Ates Z, Can-Eke B, Suzen S, Iscan M, Buyukbingol E. Effects of a benzimidazole compound on monooxygenase activities. Farmaco 1997; 52: 703-706.
19. Ates-Alagoz Z, Kus C, Coban T. Synthesis and antioxidant properties of some novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments. Journal of Enzyme Inhibition and Medicinal Chemistry 2005; 20 (4): 325-331.
20. Ates-Alagoz Z, Coleman N, Martin M, Wan A, Adejare A. In vitro anticancer properties of novel radiosensitizer analogs. Chem Biol & Drug Design 2012; 80: 853–861.
21. Shavnya A, Hesp KD, Mascitti V, Smith AC. Palladium-catalyzed synthesis of (hetero)aryl alkyl sulfones from (hetero)aryl boronic acids, unactivated alkyl halides, and potassium metabisulfite. Angewandte Chemie International Edition 2015; 54: 13571-13575.
22. Goker H, Alp M, Ates-Alagoz Z, Yıldız S. Synthesis and potent antifungal activity against Candida species of some novel 1H-benzimidazoles, Journal of Heterocyclic Chemistry. 2009; 46 (5): 936-948.
23. Zengin-Karadayi F, Yaman M, Kisla MM, Keskus AG, Konu O et al. Design, synthesis and anticancer/antiestrogenic activities of novel indole-benzimidazoles. Bioorganic Chemistry 2020; 100.
24. Zengin-Karadayi F, Yaman M, Kisla MM, Konu O, Ates-Alagoz Z. Design, synthesis, anticancer activity, molecular docking and ADME studies of novel methylsulfonyl indole-benzimidazoles in comparison with ethylsulfonyl counterparts. New Journal of Chemistry 2021; 45 (20): 9010-9019.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJJ. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193 (1): 265-275.
26. Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochemical Journal 1966; 99: 667–676.
27. Wills ED. Lipid peroxide formation in microsomes. General considerations. Biochemical Journal 1969; 113: 333–341.
28. Bishayee S, Balasubramanian AS. Lipid peroxide formation in rat brain. Journal of Neurochemistry 1971; 18: 909–920.
29. Iscan M, Arinc E, Vural N, Iscan MY. In vivo effects of 3-methylcholanthrene, phenobarbital, pyrethrum and 2,4,5-T isooctylester on liver, lung and kidney microsomal mixed-function oxidase system of guinea-pig: a comparative study. Comparative Biochemistry and Physiology 1984; 77C: 177–190.
30. Burke MD, Thompson S, Elcombe CR, Halpert J. Haaparanta T et al. Ethoxy, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology 1985; 34: 3337–3345.
31. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN et al. The Protein Data Bank. Nucleic Acids Research 2000; 28: 235-242.
32. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. Journal of Computational Chemistry 2009; 16: 2785-2791.
33. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E et al. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics 2012; 4: 17.
34. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry 2010; 31: 455-461.
35. Dassault Systèmes BIOVIA, Discovery Studio Visualizer v17.2.0.16349, San Diego: Dassault Systèmes 2017.
36. Daina A, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Nature: Scientific Reports 2017; 7 (1): 42717.
37. Daina A, Zoete V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016; 11 (11): 1117-1121.
38. Bell EW, Zhang Y. DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. Journal of Cheminformatics 2019; 11: 40.
39. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. OpenBabel: An open chemical toolbox. Journal of Cheminformatics 2011; 3: 33.
40. Castro-Alvarez A, Costa AM, Vilarrasa J. The performance of several docking programs at reproducing protein-macrolide-like crystal structures. Molecules 2017; 22 (1): 136.
41. Desai PV, Raub TJ, Blanco MJ. How hydrogen bonds impact P-glycoprotein transport and permeability. Bioorganic & Medicinal Chemistry Letters 2012; 22 (21): 6540-8.
42. Mullard A. Re-assessing the rule of 5, two decades on. Nature Reviews Drug Discovery 2018; 17: 777.
43. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001; 46 (1–3): 3–26.
44. Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. Journal of Medicinal Chemistry 2001; 44 (12): 1841-6.
45. Teague S, Davis A, Leeson P, Oprea, T. The design of leadlike combinatorial libraries. Angewandte Chemie International Edition England 1999; 38: 3743–3748.